These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 22510296)

  • 1. Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity.
    Chen J; Hou J; Zhang J; An Y; Zhang X; Yue L; Liu J; Li X
    Eur J Pharmacol; 2012 May; 682(1-3):161-70. PubMed ID: 22510296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1.
    Chen J; Lan T; Hou J; Zhang J; An Y; Tie L; Pan Y; Liu J; Li X
    Int J Biochem Cell Biol; 2012 May; 44(5):759-69. PubMed ID: 22305890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer.
    Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F
    Biochem Pharmacol; 2011 Nov; 82(9):1079-89. PubMed ID: 21803026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production.
    Chen J; Liu B; Yuan J; Yang J; Zhang J; An Y; Tie L; Pan Y; Li X
    Mol Oncol; 2012 Feb; 6(1):62-72. PubMed ID: 22153388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR; Zhang H; Blanck G
    Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
    J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
    Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
    Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
    J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells.
    Duan L; Shen H; Zhao G; Yang R; Cai X; Zhang L; Jin C; Huang Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1010-6. PubMed ID: 24657266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
    Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
    Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
    Schiller JH; Bittner G; Storer B; Willson JK
    Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
    Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
    Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.